The National Institutes of Health provided a non-recommendation for the use of ivermectin in COVID-19, stating that there was:
“insufficient evidence … to recommend either for or against the use of ivermectin for the treatment of COVID-19.”
The process for reaching that non-recommendation, however, is opaque. The Panel members responsible for therapy recommendations are disclosed and also that:
Continue reading “Grotesque conflicts of interest on NIH ivermectin non-recommendation”